EGFR testing in lung cancer is ready for prime time

被引：208

作者：

Hirsch, Fred R. ^{[1
]}

Bunn, Paul A., Jr. ^{[1
]}

机构：

[1] Univ Colorado, Ctr Canc, Aurora, CO USA

来源：

LANCET ONCOLOGY | 2009年 / 10卷 / 05期

关键词：

GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; PHASE-III; MUTATIONS; GEFITINIB; PREDICTORS; CETUXIMAB;

D O I：

10.1016/S1470-2045(09)70110-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：432 / 433

页数：2

相关论文

共 12 条

[1]

[Anonymous], J THORAC ONCOL

[2] Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis [J].

Hirsch, FR ;

Varella-Garcia, M ;

Bunn, PA ;

Di Maria, MV ;

Veve, R ;

Bremnes, RM ;

Barón, AE ;

Zeng, C ;

Franklin, WA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) :3798-3807

[3] Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy [J].

Hirsch, Fred R. ;

Herbst, Roy S. ;

Olsen, Christine ;

Chansky, Kari ;

Crowley, John ;

Kelly, Karen ;

Franklin, Wilbur A. ;

Bunn, Paul A., Jr. ;

Varella-Garcia, Marileila ;

Gandara, David R. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3351-3357

[4] Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer [J].

Hirsch, Fred R. ;

Varella-Garcia, Marileila ;

Bunn, Paul A., Jr. ;

Franklin, Wilbur A. ;

Dziadziuszko, Rafal ;

Thatcher, Nick ;

Chang, Alex ;

Parikh, Purvish ;

Rodrigues Pereira, Jose ;

Ciuleanu, Tudor ;

von Pawel, Joachim ;

Watkins, Claire ;

Flannery, Angela ;

Ellison, Gillian ;

Donald, Emma ;

Knight, Lucy ;

Parums, Dinah ;

Botwood, Nicholas ;

Holloway, Brian .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :5034-5042

[5] A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with taxane/carboplatin versus taxane/carboplatin alone as first-line treatment for patients with advanced/metastatic non-small cell lung cancer (NSCLC) [J].

Lynch, Thomas J. ;

Patel, Taral ;

Dreisbach, Luke ;

McCleod, Michael ;

Heim, William J. ;

Robert, Hermann ;

Eugene, Paschold ;

Virginie, Pautret ;

Weber, Martin R. ;

Woytowitz, David .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S340-S341

[6] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[7] Detection of mutations in EGFR in circulating lung-cancer cells [J].

Maheswaran, Shyamala ;

Sequist, Lecia V. ;

Nagrath, Sunitha ;

Ulkus, Lindsey ;

Brannigan, Brian ;

Collura, Chey V. ;

Inserra, Elizabeth ;

Diederichs, Sven ;

Iafrate, A. John ;

Bell, Daphne W. ;

Digumarthy, Subba ;

Muzikansky, Alona ;

Irimia, Daniel ;

Settleman, Jeffrey ;

Tompkins, Ronald G. ;

Lynch, Thomas J. ;

Toner, Mehmet ;

Haber, Daniel A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :366-377

[8]

MOK TS, 2008, J THORAC ONCOL, V3, P1487

[9]

PIRKER R, 2008, J CLIN ONCOL S, V26, pS1006

[10]

RICHARDSON F, 2008, J THORAC ONCOL, V3, pS269